MGTX
MGTX clinical trials: MeiraGTx Holdings plc
Every trial on ClinicalTrials.gov where MeiraGTx Holdings plc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MGTX on the catalyst calendar · MGTX registry changes
- Primary completion Oct 2029Sponsor estimatePhase 1/Phase 2NCT05894343Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's DiseaseMeiraGTx, LLC · Parkinson's DiseaseActive, not recruitingMGTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 10, 2026ActualPhase 1NCT02446249Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary...MeiraGTx, LLC · Squamous Cell Head and Neck CancerCompletedMGTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 2NCT05926765A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaMeiraGTx, LLC · Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsActive, not recruitingMGTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2027Sponsor estimateNo phase registeredNCT05060341Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced XerostomiaMeiraGTx, LLC · Radiation-induced XerostomiaActive, not recruitingMGTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2032Sponsor estimatePhase 2NCT06544798Long-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaMeiraGTx, LLC · Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsEnrolling by invitationMGTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 6, 2024ActualPhase 1/Phase 2NCT05603312A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's ParticipantsMeiraGTx, LLC · Parkinson's DiseaseCompletedMGTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner